Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Stan J. F. Hartman"'
Autor:
Stan J. F. Hartman, Joost G. E. Swaving, Stijn W. van Beek, Bianca D. van Groen, Marika de Hoop, Tjitske M. van der Zanden, Rob ter Heine, Saskia N. de Wildt
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Background: Modeling and simulation is increasingly used to study pediatric pharmacokinetics, but clinical implementation of age-appropriate doses lags behind. Therefore, we aimed to develop model-informed doses using published pharmacokinetic data a
Externí odkaz:
https://doaj.org/article/afbf1afcd27242b68dc6c6e9d324dabe
Autor:
Saskia N. de Wildt, Nienke N Hagedoorn, Parth J. Upadhyay, Stan J. F. Hartman, Michiel van der Flier, Roger J. M. Brüggemann, Catherijne A. J. Knibbe, Henriëtte A. Moll, Ron A. A. Mathôt, Michiel F. Schreuder
Publikováno v:
Clinical Pharmacokinetics, 60(10), 1361-1372. Adis
Clinical Pharmacokinetics, 60, 1361-1372
Clinical Pharmacokinetics. ADIS INT LTD
Clinical Pharmacokinetics
Clinical Pharmacokinetics, 60, 10, pp. 1361-1372
Clinical pharmacokinetics, 60(10), 1361-1372. Adis International Ltd
Clinical Pharmacokinetics, 60, 1361-1372
Clinical Pharmacokinetics. ADIS INT LTD
Clinical Pharmacokinetics
Clinical Pharmacokinetics, 60, 10, pp. 1361-1372
Clinical pharmacokinetics, 60(10), 1361-1372. Adis International Ltd
Background and Objective Ceftriaxone is a cornerstone antibiotic for critically ill children with severe infections. Despite its widespread use, information on the pharmacokinetics of ceftriaxone is lacking in this population. We aimed to determine c
Autor:
Saskia N. de Wildt, Roger J. M. Brüggemann, L Orriëns, Stan J. F. Hartman, Michiel F. Schreuder, Nada Dia
Publikováno v:
Clinical Pharmacokinetics, 59(2), 173-205. Adis
Clinical Pharmacokinetics, 59, 2, pp. 173-205
Clinical Pharmacokinetics, 59, 173-205
Clinical Pharmacokinetics
Clinical Pharmacokinetics, 59, 2, pp. 173-205
Clinical Pharmacokinetics, 59, 173-205
Clinical Pharmacokinetics
Background Pharmacokinetics (PK) are severely altered in critically ill patients due to changes in volume of distribution (Vd) and/or drug clearance (Cl). This affects the target attainment of antibiotics in critically ill children. We aimed to ident
Publikováno v:
Paediatric Drugs
Pediatric Drugs, 22(4), 433-444
Paediatric Drugs, 22, 433-444
Paediatric Drugs, 22, 4, pp. 433-444
Pediatric Drugs, 22(4), 433-444
Paediatric Drugs, 22, 433-444
Paediatric Drugs, 22, 4, pp. 433-444
Contains fulltext : 225119.pdf (Publisher’s version ) (Open Access) BACKGROUND: The Dutch Pediatric Formulary (DPF) increasingly bases its guidelines on model-based dosing simulations from pharmacokinetic studies. This resulted in nationwide dose c
Autor:
Joost van Rosmalen, Nadies E C van de Water, Michiel F. Schreuder, Dick Tibboel, Saskia N. de Wildt, Stan J. F. Hartman, Oliver Hartmann, Joachim Struck, Janin Schulte, Remi Beunders, Peter Pickkers, Alexandra J M Zwiers
Publikováno v:
Clinical Chemistry and Laboratory Medicine, 58(11), 1911-1919. De Gruyter
Clinical Chemistry and Laboratory Medicine, 58, 11, pp. 1911-1919
Clinical Chemistry and Laboratory Medicine, 58, 1911-1919
Clinical Chemistry and Laboratory Medicine, 58, 11, pp. 1911-1919
Clinical Chemistry and Laboratory Medicine, 58, 1911-1919
Objectives Acute kidney injury (AKI) is common in critically ill children, but current biomarkers are suboptimal. Proenkephalin A 119–159 (PENK) is a promising new biomarker for AKI in adults, but pediatric data is lacking. We determined PENK refer
Autor:
Stan J. F. Hartman, Parth J. Upadhyay, Ron A. A. Mathôt, Michiel van der Flier, Michiel F. Schreuder, Roger J. Brüggemann, Catherijne A. Knibbe, Saskia N. de Wildt
Publikováno v:
Journal of Antimicrobial Chemotherapy, 77, 1725-1732
Journal of Antimicrobial Chemotherapy, 77, 6, pp. 1725-1732
Journal of Antimicrobial Chemotherapy, 77(6), 1725-1732. OXFORD UNIV PRESS
The Journal of antimicrobial chemotherapy, 77(6), 1725-1732. Oxford University Press
Journal of Antimicrobial Chemotherapy, 77(6), 1725-1732. Oxford University Press
Journal of Antimicrobial Chemotherapy, 77, 6, pp. 1725-1732
Journal of Antimicrobial Chemotherapy, 77(6), 1725-1732. OXFORD UNIV PRESS
The Journal of antimicrobial chemotherapy, 77(6), 1725-1732. Oxford University Press
Journal of Antimicrobial Chemotherapy, 77(6), 1725-1732. Oxford University Press
Background Cefotaxime is frequently used in critically ill children, however pharmacokinetic (PK) studies to support adequate dosing in this patient population are limited. Objectives To characterize cefotaxime PK in critically ill children and evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f4c6e373e3a403f9cfc33617411f764
http://hdl.handle.net/2066/251196
http://hdl.handle.net/2066/251196
Autor:
Stan J. F. Hartman, Birgit C. P. Koch, Navin P. Boeddha, Gertjan J. Driessen, Rogier Donders, Ebru Ekinci, Saskia N. de Wildt, Jan A. Hazelzet
Publikováno v:
European Journal of Clinical Microbiology and Infectious Diseases, 38, 7, pp. 1255-1260
European Journal of Clinical Microbiology and Infectious Diseases, 38, 1255-1260
European Journal of Clinical Microbiology & Infectious Diseases, 38(7), 1255-1260. Springer-Verlag
European Journal of Clinical Microbiology & Infectious Diseases
European Journal of Clinical Microbiology and Infectious Diseases, 38, 1255-1260
European Journal of Clinical Microbiology & Infectious Diseases, 38(7), 1255-1260. Springer-Verlag
European Journal of Clinical Microbiology & Infectious Diseases
Reduced target attainment of β-lactam antibiotics is reported in critically ill patients. However, as target attainment of cefotaxime in severely ill pediatric sepsis patients may differ from adults due to age-related variation in pharmacokinetics,
Autor:
Stan J. F. Hartman, Catherijne A. J. Knibbe, Joost van Rosmalen, Bianca D van Groen, Saskia N. de Wildt, N. Harry Hendrikse, Karel Allegaert, Birgit C. P. Koch, Dick Tibboel, Albert D. Windhorst, Elke H. J. Krekels, Esther van Duijn, Miriam G. Mooij, Wouter H. J. Vaes
Publikováno v:
Clinical Pharmacology and Therapeutics, 109(1), 140-149. Wiley-Blackwell
Clinical Pharmacology and Therapeutics, Epub 13 May
Clinical Pharmacology and Therapeutics, 109, 140-149
van Groen, B D, Krekels, E H J, Mooij, M G, van Duijn, E, Vaes, W H J, Windhorst, A D, van Rosmalen, J, Hartman, S J F, Hendrikse, N H, Koch, B C P, Allegaert, K, Tibboel, D, Knibbe, C A J & de Wildt, S N 2021, ' The Oral Bioavailability and Metabolism of Midazolam in Stable Critically Ill Children: A Pharmacokinetic Microtracing Study ', Clinical Pharmacology and Therapeutics, vol. 109, no. 1, pp. 140-149 . https://doi.org/10.1002/cpt.1890, https://doi.org/10.1002/cpt.1890
Clinical Pharmacology and Therapeutics
Clinical Pharmacology and Therapeutics, 109, 1, pp. 140-149
Clinical Pharmacology and Therapeutics, Epub 13 May
Clinical Pharmacology and Therapeutics, 109, 140-149
van Groen, B D, Krekels, E H J, Mooij, M G, van Duijn, E, Vaes, W H J, Windhorst, A D, van Rosmalen, J, Hartman, S J F, Hendrikse, N H, Koch, B C P, Allegaert, K, Tibboel, D, Knibbe, C A J & de Wildt, S N 2021, ' The Oral Bioavailability and Metabolism of Midazolam in Stable Critically Ill Children: A Pharmacokinetic Microtracing Study ', Clinical Pharmacology and Therapeutics, vol. 109, no. 1, pp. 140-149 . https://doi.org/10.1002/cpt.1890, https://doi.org/10.1002/cpt.1890
Clinical Pharmacology and Therapeutics
Clinical Pharmacology and Therapeutics, 109, 1, pp. 140-149
Midazolam is metabolized by the developmentally regulated intestinal and hepatic drug-metabolizing enzyme cytochrome P450 (CYP) 3A4/5. It is frequently administered orally to children, yet knowledge is lacking on the oral bioavailability in term neon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b91723dc49e8ea4eb1c1336430edfbb
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/232102
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/232102
Autor:
Stan J. F. Hartman, R. ter Heine, S. Van Beek, TM van der Zanden, M. De Hoop, BD van Groen, Joost G E Swaving, SN de Wildt
Publikováno v:
Pediatric Critical Care Medicine. 22:259-259
Autor:
Saskia N. de Wildt, Tjitske M van der Zanden, Stijn W van Beek, Stan J. F. Hartman, Marika de Hoop, Rob ter Heine, Joost G E Swaving, Bianca D van Groen
Publikováno v:
Critical Care Medicine. 49:426-426